Author: Rachel Tan

Rachel is a marketing graduate from the National University of Singapore. She enjoys researching and writing extensively on healthcare, medicine, and technology in her personal time. In her free time, she enjoys reading books on psychology, science-related mysteries, and documentaries as a personal interest.

In today’s digital age, the integration of big data and data analytics is driving a paradigm shift in the healthcare industry (1). The vast amount of health-related information generated daily offers healthcare professionals unprecedented opportunities to improve patient care, enhance clinical outcomes, and streamline operations (1). By leveraging data analytics, healthcare providers can unlock valuable insights, make informed decisions, and deliver personalized and efficient care. This article explores the transformative potential of big data in healthcare and highlights how healthcare professionals can leverage data analytics to revolutionize patient care. Predictive Analytics and Early Detection: Data analytics empowers healthcare professionals to…

Read More

Advancements in genomic research have opened new possibilities for personalised medicine, revolutionising the way healthcare is delivered (1). The integration of genomics into clinical practice holds great promise for improving patient outcomes and tailoring treatments to individual genetic profiles (1). In this article, we will explore the role of healthcare professionals in leveraging genomics for personalised medicine and the implications it has for patient care. Understanding Genomics and Personalized Medicine: Genomics refers to the study of an individual’s entire set of genes and their interactions (2). Personalised medicine, on the other hand, aims to deliver targeted healthcare based on an…

Read More

Since ChatGPT became a well-known name worldwide in early 2023, it has been trialled by millions and applied to a variety of industries across the field, including healthcare. As a large language model tools (LLMs), it aims to imitate understanding, processing, and producing human communication. Recently, WHO issued an announcement calling for safe and ethical AI research for health [1]. It proposes a 6 core principles plan to address the concerns for the technologies to be used in safe, effective and ethical manner:  protect autonomy;  promote human well-being, human safety, and the public interest;  ensure transparency, explainability, and intelligibility;  foster…

Read More

New Data Shows Motor Gains with SRP-9001 Gene Therapy in DMD Duchenne Muscular Dystrophy (DMD) is a genetic disorder that causes progressive muscle degeneration and weakness. It is the most common form of muscular dystrophy in children, predominantly affecting males. Historically, DMD has resulted in the loss of the ability to walk between ages 7 and 13 years, and death in the teens or 20s. The estimated prevalence of DMD is about 1 in every 5,000 males aged 5-9 years [1]. The Disease Pathway Source: Romina F, Natasha C (2021) [2] DMD is caused by mutations in the gene…

Read More

How Advancements in Techniques and Technologies Empower Healthcare Professionals to Transform Patient Care The discipline of medicine has undergone a revolution thanks to improvements in surgical methods and technology, which have greatly improved patient care and results (1). These advancements, which range from robotic surgery assistance to minimally invasive procedures, present new chances and possibilities for healthcare workers. This essay examines the effects of these developments on medical practitioners and emphasises how drastically they alter the surgical scene. Enhanced Precision and Accuracy: Technology and surgical technique advancements have made it possible to perform treatments with greater accuracy and precision. For…

Read More

Psoriasis is a chronic, immune-mediated skin disorder that affects millions of people worldwide, causing significant physical and emotional distress. With a prevalence of at least 100 million individuals globally, affecting 2-3% of the total population [1], psoriasis poses a serious global health concern. While effective systemic therapies exist, many patients with moderate-to-severe psoriasis are undertreated or remain untreated, leading to dissatisfaction with current treatment options. In March 2023, the European Commission (EC) approved Deucravacitinib (Sotyktu), an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, for the treatment of moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy [2,3].…

Read More